The GenomAMR-Africa project, launched in 2025 under the auspices of Africa CDC and the Wellcome Sanger Institute, represents the most ambitious genomic surveillance initiative for antimicrobial resistance ever undertaken on the African continent. Using whole-genome sequencing (WGS), the project aims to map the spread of antibiotic resistance genes across national borders and identify priority transmission corridors. In its first year of operation, GenomAMR-Africa sequenced over 15,000 bacterial isolates collected from 28 African countries. Phylogenetic analyses revealed unexpected propagation patterns: NDM-5 type carbapenem resistance genes, initially identified in North Africa, spread to West Africa via trans-Saharan trade corridors rather than through the traditionally suspected north-south migration routes. Dr. Iruka Okeke, scientific advisor to the project, explained that "resistance does not respect borders. Our genomic approach allows us to see, for the first time, how resistance genes travel across the continent, often following trade routes and migration flows." She emphasized the importance of these data for guiding public health interventions. The project has also established an open-access genomic data sharing platform, enabling researchers and policymakers from 54 African countries to visualize the geographic distribution of key resistance determinants in real time. This unprecedented transparency is hailed by the international scientific community as a model for South-South collaboration.